Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Naltrexone And Bupropion

A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes

Orexigen Therapeutics, Inc · Phase 3 · Completed · Enrollment 505

NCT00474630

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

X axis: threshold category. Y axis: participants reaching threshold, %.

44.5318.87
≥5%
18.495.66
≥10%
≥15%
≥20%
Show as table
Arm≥5%≥10%≥15%≥20%
NB3244.53%18.49%n/rn/r
Placebo18.87%5.66%n/rn/r

Not shown

Every selected arm is drawn.